+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Neurodiagnostics Market by Product (Clinical Testing Instrument, Diagnostic & Imaging System, Reagent & Consumable), Indication (Epilepsy, Headache Disorder, Neurodegenerative Diseases), End User - Forecast 2024-2030- Product Image
Global Neurodiagnostics Market by Product (Clinical Testing Instrument, Diagnostic & Imaging System, Reagent & Consumable), Indication (Epilepsy, Headache Disorder, Neurodegenerative Diseases), End User - Forecast 2024-2030- Product Image
Sale

Global Neurodiagnostics Market by Product (Clinical Testing Instrument, Diagnostic & Imaging System, Reagent & Consumable), Indication (Epilepsy, Headache Disorder, Neurodegenerative Diseases), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5014094
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neurodiagnostics Market size was estimated at USD 7.34 billion in 2023, USD 7.97 billion in 2024, and is expected to grow at a CAGR of 8.71% to reach USD 13.18 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neurodiagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neurodiagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neurodiagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., Adeor Medical AG, Advanced Brain Monitoring, Inc., Canon Medical Systems USA, Inc., DEYMED Diagnostic s.r.o., F. Hoffmann-La Roche Ltd., GE Healthcare, Koninklijke Philips N.V., Lifelines Neuro Company, LLC, Medtronic PLC, Mitsar Co., Ltd., Natus Medical Incorporated, Nihon Kohden Corporation, Siemens Healthineers AG, and Thermo Fisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Neurodiagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Clinical Testing Instrument
      • NGS Instrument
      • PCR Instrument
      • Sanger Sequencer
    • Diagnostic & Imaging System
      • Angiography System
      • CT Scanner
      • EEG System
      • EMG Device
      • MEG Device
      • MRI System
      • PET Scanner
      • Ultrasound Imaging System
    • Reagent & Consumable
      • Antibody
      • Buffer
      • Enzyme, Protein, & Peptide
      • Media & Sera
      • Probe
      • Solvent
  • Indication
    • Epilepsy
    • Headache Disorder
    • Neurodegenerative Diseases
    • Sleep Disorder
    • Stroke
  • End User
    • Ambulatory Care Center
    • Diagnostic Laboratory & Imaging Center
    • Hospital & Clinic
    • Neurology Center
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Neurodiagnostics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neurodiagnostics Market?
  3. What are the technology trends and regulatory frameworks in the Neurodiagnostics Market?
  4. What is the market share of the leading vendors in the Neurodiagnostics Market?
  5. Which modes and strategic moves are suitable for entering the Neurodiagnostics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Neurodiagnostics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of neurological disorders worldwide
5.1.1.2. Growing awareness among patients for early disease diagnosis for effective treatment
5.1.1.3. Growing adoption of innovative diagnostic technologies
5.1.2. Restraints
5.1.2.1. High cost associated with the neurodiagnostic devices
5.1.3. Opportunities
5.1.3.1. Advances in genomics and proteomics for neurodegenerative disorders diagnosis
5.1.3.2. Ongoing clinical trials for neurological disease
5.1.4. Challenges
5.1.4.1. Limited availability of skilled healthcare professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Neurodiagnostics Market, by Product
6.1. Introduction
6.2. Clinical Testing Instrument
6.3.1. NGS Instrument
6.3.2. PCR Instrument
6.3.3. Sanger Sequencer
6.3. Diagnostic & Imaging System
6.4.1. Angiography System
6.4.2. CT Scanner
6.4.3. EEG System
6.4.4. EMG Device
6.4.5. MEG Device
6.4.6. MRI System
6.4.7. PET Scanner
6.4.8. Ultrasound Imaging System
6.4. Reagent & Consumable
6.5.1. Antibody
6.5.2. Buffer
6.5.3. Enzyme, Protein, & Peptide
6.5.4. Media & Sera
6.5.5. Probe
6.5.6. Solvent
7. Neurodiagnostics Market, by Indication
7.1. Introduction
7.2. Epilepsy
7.3. Headache Disorder
7.4. Neurodegenerative Diseases
7.5. Sleep Disorder
7.6. Stroke
8. Neurodiagnostics Market, by End User
8.1. Introduction
8.2. Ambulatory Care Center
8.3. Diagnostic Laboratory & Imaging Center
8.4. Hospital & Clinic
8.5. Neurology Center
9. Americas Neurodiagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Neurodiagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Neurodiagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories Inc.
13.1.2. Adeor Medical AG
13.1.3. Advanced Brain Monitoring, Inc.
13.1.4. Canon Medical Systems USA, Inc.
13.1.5. DEYMED Diagnostic s.r.o.
13.1.6. F. Hoffmann-La Roche Ltd.
13.1.7. GE Healthcare
13.1.8. Koninklijke Philips N.V.
13.1.9. Lifelines Neuro Company, LLC
13.1.10. Medtronic PLC
13.1.11. Mitsar Co., Ltd.
13.1.12. Natus Medical Incorporated
13.1.13. Nihon Kohden Corporation
13.1.14. Siemens Healthineers AG
13.1.15. Thermo Fisher Scientific, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. NEURODIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. NEURODIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. NEURODIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NEURODIAGNOSTICS MARKET DYNAMICS
FIGURE 7. NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. NEURODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. NEURODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. NEURODIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. NEURODIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 8. NEURODIAGNOSTICS MARKET SIZE, BY NGS INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. NEURODIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. NEURODIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 13. NEURODIAGNOSTICS MARKET SIZE, BY ANGIOGRAPHY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. NEURODIAGNOSTICS MARKET SIZE, BY CT SCANNER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. NEURODIAGNOSTICS MARKET SIZE, BY EEG SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. NEURODIAGNOSTICS MARKET SIZE, BY EMG DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. NEURODIAGNOSTICS MARKET SIZE, BY MEG DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. NEURODIAGNOSTICS MARKET SIZE, BY MRI SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. NEURODIAGNOSTICS MARKET SIZE, BY PET SCANNER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. NEURODIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 23. NEURODIAGNOSTICS MARKET SIZE, BY ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. NEURODIAGNOSTICS MARKET SIZE, BY BUFFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. NEURODIAGNOSTICS MARKET SIZE, BY ENZYME, PROTEIN, & PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. NEURODIAGNOSTICS MARKET SIZE, BY MEDIA & SERA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. NEURODIAGNOSTICS MARKET SIZE, BY PROBE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. NEURODIAGNOSTICS MARKET SIZE, BY SOLVENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. NEURODIAGNOSTICS MARKET SIZE, BY HEADACHE DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. NEURODIAGNOSTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. NEURODIAGNOSTICS MARKET SIZE, BY SLEEP DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. NEURODIAGNOSTICS MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORY & IMAGING CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. CANADA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. CANADA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 61. CANADA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 62. CANADA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 63. CANADA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. CANADA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 67. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 68. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 69. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. CHINA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. CHINA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 93. CHINA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 94. CHINA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 95. CHINA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. CHINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. INDIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. INDIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 99. INDIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 100. INDIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 101. INDIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. INDIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 111. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 112. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 113. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 118. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 124. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 125. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 130. SINGAPORE NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 131. SINGAPORE NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. SINGAPORE NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 136. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 137. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 142. TAIWAN NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 143. TAIWAN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. TAIWAN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 147. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 148. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 149. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. VIETNAM NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. VIETNAM NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 153. VIETNAM NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 154. VIETNAM NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 155. VIETNAM NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. VIETNAM NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 164. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 166. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 167. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 168. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. DENMARK NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. EGYPT NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. EGYPT NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 172. EGYPT NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 173. EGYPT NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 174. EGYPT NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. EGYPT NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 178. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 179. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 180. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. FINLAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 184. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 185. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 186. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 190. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 191. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 192. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 193. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. ISRAEL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. ISRAEL NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 196. ISRAEL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 197. ISRAEL NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 198. ISRAEL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. ISRAEL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. ITALY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. ITALY NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 202. ITALY NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 203. ITALY NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 204. ITALY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 205. ITALY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. NORWAY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. NORWAY NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 220. NORWAY NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 221. NORWAY NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 222. NORWAY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 223. NORWAY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. POLAND NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. POLAND NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 226. POLAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 227. POLAND NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 228. POLAND NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 229. POLAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. QATAR NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. QATAR NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 232. QATAR NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 233. QATAR NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 234. QATAR NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 235. QATAR NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 256. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 257. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 258. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 259. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 263. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 264. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 265. SWEDEN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 271. SWITZERLAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 273. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 274. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 275. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 276. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 277. TURKEY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2018-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2018-2030 (USD MILLION)
TABLE 288. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. NEURODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 291. NEURODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 292. NEURODIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories Inc.
  • Adeor Medical AG
  • Advanced Brain Monitoring, Inc.
  • Canon Medical Systems USA, Inc.
  • DEYMED Diagnostic s.r.o.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Lifelines Neuro Company, LLC
  • Medtronic PLC
  • Mitsar Co., Ltd.
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.97 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.18 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Neurodiagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Neurodiagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Global Neurodiagnostic Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis - Product Image

Global Neurodiagnostic Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • Report
  • 204 Pages
  • Global
From
Neurodiagnostics - Global Strategic Business Report - Product Image

Neurodiagnostics - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Global Neurodiagnostics Market 2024-2028 - Product Image

Global Neurodiagnostics Market 2024-2028

  • Report
  • 167 Pages
  • Global
From
Neurodiagnostic and Monitoring Devices Market in US 2024-2028 - Product Image

Neurodiagnostic and Monitoring Devices Market in US 2024-2028

  • Report
  • 165 Pages
  • United States
From

About the Neurodiagnostics Market

The Neurodiagnostics market is a subset of the Diagnostics industry, focusing on the diagnosis and treatment of neurological disorders. It includes a range of technologies and services, such as imaging, EEG, EMG, and evoked potentials, to diagnose and monitor neurological conditions. Neurodiagnostics also includes the use of biomarkers to detect and monitor neurological diseases. The Neurodiagnostics market is driven by the increasing prevalence of neurological disorders, the development of new technologies, and the growing demand for personalized medicine. Additionally, the increasing focus on preventive healthcare and the rising awareness of neurological disorders are expected to drive the market. Some companies in the Neurodiagnostics market include Philips Healthcare, Siemens Healthineers, GE Healthcare, Medtronic, and Natus Medical. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.